Clinical and functional significance of loss of caveolin‐1 expression in breast cancer‐associated fibroblasts
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Loss of caveolin‐1 (Cav‐1) expression in breast cancer‐associated fibroblasts (CAFs) is predictive of poor prognosis in breast cancer, but its function has not been established. Our study tested the hypotheses that loss of Cav‐1 expression in breast fibroblasts was associated with poor prognosis in breast cancer, through promotion of breast cancer cell invasion. Cav‐1 stromal expression was immunohistochemically assessed in 358 breast cancers. Cav‐1 expression in primary breast fibroblasts was analysed by western blot. Modified Boyden chamber assays determined fibroblast ability to promote invasion of breast cancer cells. The impact of siRNA silencing of Cav‐1 in fibroblasts was evaluated using invasion assays and 3D co‐culture assays. Loss of Cav‐1 expression in breast stroma was significantly associated with decreased breast cancer‐specific and disease‐free survival ( p = 0.01). Mean survival was 72 months (Cav‐1 + group) versus 29.5 months (Cav‐1 − group). This was confirmed in multivariate analysis. Cav‐1 expression was significantly decreased in CAFs compared to normal fibroblasts ( p = 0.01) and was associated with increased invasion‐promoting capacity. Cav‐1 siRNA‐treated fibroblasts promoted significantly increased invasion of MDA‐MB‐468 and T47D breast cancer cells from 27% (control) to 67% ( p = 0.006) and from 37% to 56%, respectively ( p = 0.01). 3D co‐cultures of MDA‐MB‐468 cells with myoepithelial cells led to the formation of organized cohesive structures when cultured with conditioned media from fibroblasts but resulted in a disorganized appearance in the presence of conditioned media from Cav‐1 siRNA‐treated fibroblasts, accompanied by loss of E‐cadherin expression in tumour cells. Our data confirm that loss of stromal Cav‐1 in breast cancer predicts poor outcome. At a functional level, Cav‐1‐deficient CAFs are capable of significantly increasing the invasive capacity of breast cancer cells. Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · cited 2×
“By imitation of activated ‘wound repair’ fibroblasts, CAFs are thought to promote carcinoma progression by stimulating epithelial cell growth, migration, and invasion [1,5,6].”
BackgroundKnow thy neighbor: stromal cells can contribute oncogenic signals
Tlsty, T. D., & Hein, P. W. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00156-8 · Cited by 425
Cited by
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Turning foes to friends: targeting cancer-associated fibroblasts
Chen, X., & Song, E. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0004-1 · Cited by 1,879
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Costa, A., Kieffer, Y., Scholer-Dahirel, A., Pelon, F., Bourachot, B., Cardon, M., Sirven, P., Magagna, I., Fuhrmann, L., Bernard, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.011 · Cited by 1,705
Cancer associated-fibroblast-derived exosomes in cancer progression
Li, C., Teixeira, A. F., Zhu, H.-J., & ten Dijke, P. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01463-y · Cited by 336
Hosein, A. N., Huang, H., Wang, Z., Parmar, K., Du, W., Huang, J., Maitra, A., Olson, E., Verma, U., & Brekken, R. A. (2019) · JCI Insight · doi:10.1172/jci.insight.129212 · Cited by 302
Metadata
- Authors
- Simpkins, S. A., Hanby, A. M., Holliday, D. L., & Speirs, V.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2012-05-23
- Volume
- 227
- Issue
- 4
- Pages
- 490-498
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2011962069
- Cited by
- 100
- References
- 2
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical and functional significance of loss of caveolin‐1 expression in breast cancer‐associated fibroblasts. https://app.cochat.ai/papers/10.1002/path.4034
- The paper
- Simpkins, S. A., Hanby, A. M., Holliday, D. L., & Speirs, V. (2012). Clinical and functional significance of loss of caveolin‐1 expression in breast cancer‐associated fibroblasts. The Journal of Pathology. https://doi.org/10.1002/path.4034
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.